{"DataElement":{"publicId":"3110935","version":"2","preferredName":"Specimen Laboratory Procedure Specimen Gastrointestinal Urology Laboratory Test Type","preferredDefinition":"Text classification for a type of gastrointestinal (GI) or urologic laboratory procedure performed on a biospecimen.","longName":"SPEC_GI_URO_TEST_TP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2664760","version":"1","preferredName":"Specimen Laboratory Procedure","preferredDefinition":"information related to a medical procedure that involves testing a sample of blood, urine, or other substance from the body.","longName":"SPEC_LABPROC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2241613","version":"1","preferredName":"Specimen","preferredDefinition":"Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.","longName":"C19157","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-2242-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2486250","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15A9DA1A-D89C-6C6C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-07","modifiedBy":"ONEDATA","dateModified":"2006-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"358C8096-E898-6B3D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-18","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-07-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"**Laboratory Clean-Up**","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3110927","version":"2","preferredName":"Specimen Gastrointestinal Urology Laboratory Test Type","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._Type; a subdivision of a particular kind of thing._Pertaining to the stomach and intestines._The medical specialty concerned with the study, diagnosis, and treatment of diseases of the genitourinary tract._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"SPEC_GI_URO_TEST_TP","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Blood biomarker","valueDescription":"Blood Biomarker","ValueMeaning":{"publicId":"3110932","version":"1","preferredName":"Blood Biomarker","longName":"3110932","preferredDefinition":"Blood circulating throughout the body.: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blood","conceptCode":"C12434","definition":"A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"89404B82-0E38-7C65-E040-BB89AD4377DC","latestVersionIndicator":"Yes","beginDate":"2010-06-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-91DE-1659-E053-F662850AAC42","beginDate":"2010-06-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Urine biomarker","valueDescription":"Urine Biomarker","ValueMeaning":{"publicId":"3110933","version":"1","preferredName":"Urine Biomarker","longName":"3110933","preferredDefinition":"The fluid that is excreted by the kidneys.  It is stored in the bladder and discharged through the urethra.: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urine","conceptCode":"C13283","definition":"The fluid that is excreted by the kidneys.  It is stored in the bladder and discharged through the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"89404B82-0E5E-7C65-E040-BB89AD4377DC","latestVersionIndicator":"Yes","beginDate":"2010-06-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-91E8-1659-E053-F662850AAC42","beginDate":"2010-06-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Pharmacodynamics (Acetylation)","valueDescription":"Pharmacodynamics","ValueMeaning":{"publicId":"2959415","version":"1","preferredName":"Pharmacodynamics","longName":"2959415","preferredDefinition":"The study of the biochemical and physiological effects of drugs and the mechanisms of their actions, including the correlation of actions and effects of drugs with their chemical structure, also, such effects on the actions of a particular drug or drugs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacodynamics","conceptCode":"C15720","definition":"The study of the biochemical and physiological effects of drugs and the mechanisms of their actions, including the correlation of actions and effects of drugs with their chemical structure, also, such effects on the actions of a particular drug or drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77FB36AF-7290-764C-E040-BB89AD433B5C","latestVersionIndicator":"Yes","beginDate":"2009-11-09","endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-91F2-1659-E053-F662850AAC42","beginDate":"2010-10-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Insoluble Biomarker","valueDescription":"Insoluble Biomarker","ValueMeaning":{"publicId":"3212370","version":"1","preferredName":"Insoluble Biomarker","longName":"3212370","preferredDefinition":"Insoluble Biomarker","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9FA4DAFA-52C3-E2D6-E040-BB89AD431CC5","latestVersionIndicator":"Yes","beginDate":"2011-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-03-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-91FC-1659-E053-F662850AAC42","beginDate":"2011-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Soluble Biomarker","valueDescription":"Soluble Biomarker","ValueMeaning":{"publicId":"3212371","version":"1","preferredName":"Soluble Biomarker","longName":"3212371","preferredDefinition":"Capable of being dissolved in some solvent.: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soluble","conceptCode":"C64364","definition":"Capable of being dissolved in some solvent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9FA4DAFA-52E9-E2D6-E040-BB89AD431CC5","latestVersionIndicator":"Yes","beginDate":"2011-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-03-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-9206-1659-E053-F662850AAC42","beginDate":"2011-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Tumor biomarker","valueDescription":"Tumor Biomarker","ValueMeaning":{"publicId":"5406954","version":"1","preferredName":"Tumor Biomarker","longName":"5406954","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.: A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A13508E-3C18-3CDF-E050-BB89AD433795","latestVersionIndicator":"Yes","beginDate":"2016-08-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-08-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-9210-1659-E053-F662850AAC42","beginDate":"2016-08-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Hormone levels","valueDescription":"Hormone Level","ValueMeaning":{"publicId":"5485588","version":"1","preferredName":"Hormone Level","longName":"5485588","preferredDefinition":"Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.: A position on a scale measuring intensity, quality, or amount.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone","conceptCode":"C2315","definition":"Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Level","conceptCode":"C25554","definition":"A position on a scale measuring intensity, quality, or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D70B9A3-A3D1-70B7-E053-F662850ADD7C","latestVersionIndicator":"Yes","beginDate":"2016-09-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-921A-1659-E053-F662850AAC42","beginDate":"2016-09-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"RNA","valueDescription":"Ribonucleic Acid","ValueMeaning":{"publicId":"5485589","version":"1","preferredName":"Ribonucleic Acid","longName":"5485589","preferredDefinition":"Single-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ribonucleic Acid","conceptCode":"C812","definition":"Single-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D70B9A3-A3F4-70B7-E053-F662850ADD7C","latestVersionIndicator":"Yes","beginDate":"2016-09-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-9224-1659-E053-F662850AAC42","beginDate":"2016-09-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Specimen GI or Urology Test Type","valueDescription":"GI or Urology specimen test type","ValueMeaning":{"publicId":"5485590","version":"1","preferredName":"GI or Urology specimen test type","longName":"5485590","preferredDefinition":"GI or Urology specimen test type","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D70B9A3-A417-70B7-E053-F662850ADD7C","latestVersionIndicator":"Yes","beginDate":"2016-09-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-922E-1659-E053-F662850AAC42","beginDate":"2016-09-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"DNA","valueDescription":"DNA","ValueMeaning":{"publicId":"2581946","version":"1","preferredName":"DNA","longName":"2581946","preferredDefinition":"A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DNA","conceptCode":"C449","definition":"A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0D27-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-11-15","modifiedBy":"DWARZEL","dateModified":"2015-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-9238-1659-E053-F662850AAC42","beginDate":"2016-09-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Immune Checkpoint Profile","valueDescription":"Immune Checkpoint Profile","ValueMeaning":{"publicId":"5675445","version":"1","preferredName":"Immune Checkpoint Profile","longName":"5675445","preferredDefinition":"Various bioassays designed to measure levels of key regulatory molecules, such as PD-1 (PDCD1), CTLA-4, GITR (TNFRSF18), 4-1BB (TNFRSF9), OX40 (TNFRSF4), and TIGIT, that mediate immune checkpoint receptor pathways or assays to measure proliferation, expression of cell surface activation markers, and cytokine expression induced by these pathways.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Checkpoint Functional Assay","conceptCode":"C132165","definition":"Various bioassays designed to measure levels of key regulatory molecules, such as PD-1 (PDCD1), CTLA-4, GITR (TNFRSF18), 4-1BB (TNFRSF9), OX40 (TNFRSF4), and TIGIT, that mediate immune checkpoint receptor pathways or assays to measure proliferation, expression of cell surface activation markers, and cytokine expression induced by these pathways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48F89F05-7379-1865-E053-F662850A65DE","latestVersionIndicator":"Yes","beginDate":"2017-02-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-9242-1659-E053-F662850AAC42","beginDate":"2017-02-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Cytokine Expression","valueDescription":"Cytokine Expression Profile","ValueMeaning":{"publicId":"5675447","version":"1","preferredName":"Cytokine Expression Profile","longName":"5675447","preferredDefinition":"The identification and quantitation of all of the cytokines expressed in a biological sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytokine Expression Profile","conceptCode":"C129886","definition":"The identification and quantitation of all of the cytokines expressed in a biological sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48F89F05-739F-1865-E053-F662850A65DE","latestVersionIndicator":"Yes","beginDate":"2017-02-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-924C-1659-E053-F662850AAC42","beginDate":"2017-02-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"IHC","valueDescription":"Immunohistochemical Test","ValueMeaning":{"publicId":"3173904","version":"1","preferredName":"Immunohistochemical Test","longName":"3173904","preferredDefinition":"A diagnostic test in which an antibody is used to link a cellular antigen specifically to a stain that can be seen with a microscope.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunohistochemical Test","conceptCode":"C51944","definition":"A diagnostic test in which an antibody is used to link a cellular antigen specifically to a stain that can be seen with a microscope.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97EFE7BF-3668-DFE9-E040-BB89AD4369C7","latestVersionIndicator":"Yes","beginDate":"2010-12-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-12-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-9256-1659-E053-F662850AAC42","beginDate":"2017-02-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Circulating Immune Cells","valueDescription":"Circulating Immune Complex Measurement","ValueMeaning":{"publicId":"5834225","version":"1","preferredName":"Circulating Immune Complex Measurement","longName":"5834225","preferredDefinition":"The determination of the amount of circulating immune complexes present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Circulating Immune Complex Measurement","conceptCode":"C127611","definition":"The determination of the amount of circulating immune complexes present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FE30C2E-7F75-191E-E053-F662850AC157","latestVersionIndicator":"Yes","beginDate":"2017-05-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-05-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-9260-1659-E053-F662850AAC42","beginDate":"2017-05-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Pharmacokinetics","valueDescription":"Pharmacokinetics","ValueMeaning":{"publicId":"2562229","version":"1","preferredName":"Pharmacokinetics","longName":"2562229","preferredDefinition":"Pharmacokinetics","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacokinetics","conceptCode":"C15299","definition":"The characteristic movements of drugs within biological systems, as affected by absorption, distribution, binding, elimination, biotransformation, and excretion; particularly the rates of such movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C022-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-02","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-926A-1659-E053-F662850AAC42","beginDate":"2017-11-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Viral antibody titers","valueDescription":"Viral Antibody Titer","ValueMeaning":{"publicId":"6024097","version":"1","preferredName":"Viral Antibody Titer","longName":"6024097","preferredDefinition":"Having to do with a virus.: Concentration in serum of the antibody that recognizes a particular epitope expressed as the reciprocal of the highest serum dilution that produces the specific positive immunologic reaction in an appropriate test system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Viral","conceptCode":"C27985","definition":"Having to do with a virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Antibody Titer","conceptCode":"C71683","definition":"Concentration in serum of the antibody that recognizes a particular epitope expressed as the reciprocal of the highest serum dilution that produces the specific positive immunologic reaction in an appropriate test system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D1B6D6B-016D-23FB-E053-F662850AA307","latestVersionIndicator":"Yes","beginDate":"2017-11-03","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-9274-1659-E053-F662850AAC42","beginDate":"2017-11-03","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Viral load","valueDescription":"Viral Load","ValueMeaning":{"publicId":"6024098","version":"1","preferredName":"Viral Load","longName":"6024098","preferredDefinition":"The number of viral particles (usually HIV) in a sample of blood plasma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Viral Load","conceptCode":"C51952","definition":"The number of viral particles (usually HIV) in a sample of blood plasma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D1B6D6B-0192-23FB-E053-F662850AA307","latestVersionIndicator":"Yes","beginDate":"2017-11-03","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-927E-1659-E053-F662850AAC42","beginDate":"2017-11-03","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Peritoneal cytokines","valueDescription":"Peritoneal Cytokine","ValueMeaning":{"publicId":"6024099","version":"1","preferredName":"Peritoneal Cytokine","longName":"6024099","preferredDefinition":"Of or pertaining to the peritoneum.: A class of soluble glycoproteins which act nonenzymatically through specific receptors to regulate immune responses. Cytokines are derived from both immune and non-immune cells and are intercellular mediators that differ from hormones in that they are produced by a number of tissue or cell types rather than by specialized glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peritoneal","conceptCode":"C25313","definition":"Of or pertaining to the peritoneum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cytokine","conceptCode":"C20464","definition":"A class of soluble glycoproteins which act nonenzymatically through specific receptors to regulate immune responses. Cytokines are derived from both immune and non-immune cells and are intercellular mediators that differ from hormones in that they are produced by a number of tissue or cell types rather than by specialized glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D1B6D6B-01B8-23FB-E053-F662850AA307","latestVersionIndicator":"Yes","beginDate":"2017-11-03","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-9288-1659-E053-F662850AAC42","beginDate":"2017-11-03","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Circulating protein","valueDescription":"Circulating Protein","ValueMeaning":{"publicId":"6245377","version":"1","preferredName":"Circulating Protein","longName":"6245377","preferredDefinition":"Protein found in the peripheral blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Circulating Protein","conceptCode":"C150129","definition":"Protein found in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B26B125-E08F-2DC3-E053-F662850AE36E","latestVersionIndicator":"Yes","beginDate":"2018-05-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-05-01","modifiedBy":"ONEDATA","dateModified":"2018-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-9292-1659-E053-F662850AAC42","beginDate":"2018-05-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Immune Analysis and Monitoring","valueDescription":"Immunity Analysis And Monitoring","ValueMeaning":{"publicId":"6535657","version":"1","preferredName":"Immunity Analysis And Monitoring","longName":"6535657","preferredDefinition":"The protection against infectious disease conferred by the immune response. It encompasses the capacity to distinguish foreign material from self, and to neutralize, eliminate, or metabolize that which is foreign.: Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The act of observing something (and sometimes keeping a record of it).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunity","conceptCode":"C16710","definition":"The protection against infectious disease conferred by the immune response. It encompasses the capacity to distinguish foreign material from self, and to neutralize, eliminate, or metabolize that which is foreign.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Analysis","conceptCode":"C25391","definition":"Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Monitoring","conceptCode":"C61256","definition":"The act of observing something (and sometimes keeping a record of it).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78D3F9E5-67F8-5CF9-E053-F662850A43C6","latestVersionIndicator":"Yes","beginDate":"2018-10-22","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-10-22","modifiedBy":"ONEDATA","dateModified":"2018-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-929C-1659-E053-F662850AAC42","beginDate":"2018-10-22","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"NK-Cell Function","valueDescription":"Natural Killer Cell","ValueMeaning":{"publicId":"5002432","version":"1","preferredName":"Natural Killer Cell","longName":"5002432","preferredDefinition":"A type of immune cell that has granules (small particles) with enzymes that can kill tumor cells or cells infected with a virus. A natural killer cell is a type of white blood cell.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Natural Killer Cell","conceptCode":"C12536","definition":"Natural killer cells are cells that resemble large granular lymphocytes.  They do not express markers of either T or B cell lineage. They are positive for CD16, CD56, and CD 94.  These cells do possess Fc receptors for IgG and can kill target cells using antibody-dependent cell-mediated cytotoxicity. They can also use perforin to kill cells in the absence of antibody and killing may occur without previous sensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1F3DCDAD-0686-3CFA-E050-BB89AD436A35","latestVersionIndicator":"Yes","beginDate":"2015-09-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-09-08","modifiedBy":"LISU","dateModified":"2023-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-92A6-1659-E053-F662850AAC42","beginDate":"2018-09-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Glycomics","valueDescription":"Glycome","ValueMeaning":{"publicId":"4719101","version":"1","preferredName":"Glycome","longName":"4719101","preferredDefinition":"The collective identity of the entirety of carbohydrates (glycans) in an organism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glycome","conceptCode":"C69306","definition":"The collective identity of the entirety of carbohydrates (glycans) in an organism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F513CD8-AEDC-1585-E050-BB89AD434C2C","latestVersionIndicator":"Yes","beginDate":"2015-02-17","endDate":null,"createdBy":"COLBERTM","dateCreated":"2015-02-17","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-92B0-1659-E053-F662850AAC42","beginDate":"2019-04-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Receptor Activator of NF-kB ligand (RANKL)","valueDescription":"Receptor Activator Nuclear KappaB Ligand Measurement","ValueMeaning":{"publicId":"6402481","version":"1","preferredName":"Receptor Activator Nuclear KappaB Ligand Measurement","longName":"6402481","preferredDefinition":"The determination of the amount of receptor activator nuclear kappaB ligand present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Receptor Activator Nuclear KappaB Ligand Measurement","conceptCode":"C117852","definition":"The determination of the amount of receptor activator nuclear kappaB ligand present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73A54FDE-B196-7929-E053-F662850A6A93","latestVersionIndicator":"Yes","beginDate":"2018-08-17","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-17","modifiedBy":"ONEDATA","dateModified":"2018-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-92BA-1659-E053-F662850AAC42","beginDate":"2019-04-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Osteoprotegerin (OPG)","valueDescription":"Osteoprotegerin Measurement","ValueMeaning":{"publicId":"6401949","version":"1","preferredName":"Osteoprotegerin Measurement","longName":"6401949","preferredDefinition":"The determination of the amount of osteoprotegerin present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoprotegerin Measurement","conceptCode":"C116206","definition":"The determination of the amount of osteoprotegerin present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7394E67C-50D3-136A-E053-F662850A3EC6","latestVersionIndicator":"Yes","beginDate":"2018-08-16","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-16","modifiedBy":"ONEDATA","dateModified":"2018-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-92C4-1659-E053-F662850AAC42","beginDate":"2019-04-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Soluble Adhesion Molecules","valueDescription":"Soluble Cell Adhesion Molecule","ValueMeaning":{"publicId":"6700444","version":"1","preferredName":"Soluble Cell Adhesion Molecule","longName":"6700444","preferredDefinition":"Capable of being dissolved in some solvent.: A diverse family of cell surface and extracellular glycoproteins involved in cell-cell adhesion, cell-extracellular matrix adhesion, recognition, and activation. There are four main classes of cell adhesion molecules: integrins, selectins, cadherins, and immunoglobulin-like adhesion molecules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soluble","conceptCode":"C64364","definition":"Capable of being dissolved in some solvent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cell Adhesion Molecule","conceptCode":"C16393","definition":"A diverse family of cell surface and extracellular glycoproteins involved in cell-cell adhesion, cell-extracellular matrix adhesion, recognition, and activation. There are four main classes of cell adhesion molecules: integrins, selectins, cadherins, and immunoglobulin-like adhesion molecules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86BDCA9C-FF2E-6751-E053-F662850A782C","latestVersionIndicator":"Yes","beginDate":"2019-04-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-92CE-1659-E053-F662850AAC42","beginDate":"2019-04-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Immune Cell Subsets","valueDescription":"Subgroup Immune Cell","ValueMeaning":{"publicId":"6700445","version":"1","preferredName":"Subgroup Immune Cell","longName":"6700445","preferredDefinition":"A subdivision of a larger group with members often exhibiting similar characteristics.: A cell in the immune system that is involved in host defense. This category may include lymphocytes, monocytes, macrophages, neutrophils, eosinophils, basophils, mast cells, and thrombocytes. Precursor cells in these lineages may also be included.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subgroup","conceptCode":"C25693","definition":"A subdivision of a larger group with members often exhibiting similar characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immune Cell","conceptCode":"C132890","definition":"A cell in the immune system that is involved in host defense. This category may include lymphocytes, monocytes, macrophages, neutrophils, eosinophils, basophils, mast cells, and thrombocytes. Precursor cells in these lineages may also be included.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86BDCA9C-FF56-6751-E053-F662850A782C","latestVersionIndicator":"Yes","beginDate":"2019-04-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-92D8-1659-E053-F662850AAC42","beginDate":"2019-04-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"CD34+ Cells","valueDescription":"CD34 Positive Cell","ValueMeaning":{"publicId":"6700446","version":"1","preferredName":"CD34 Positive Cell","longName":"6700446","preferredDefinition":"An indication that CD34 expression has been detected in a sample.: The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD34 Positive","conceptCode":"C148068","definition":"An indication that CD34 expression has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86BDCA9C-FF7C-6751-E053-F662850A782C","latestVersionIndicator":"Yes","beginDate":"2019-04-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-92E2-1659-E053-F662850AAC42","beginDate":"2019-04-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Circulating Tumor Cells (CTC)","valueDescription":"Circulating Tumor Cell","ValueMeaning":{"publicId":"3227904","version":"1","preferredName":"Circulating Tumor Cell","longName":"3227904v1.00","preferredDefinition":"A metastatic cancer cell found in the peripheral blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Circulating Tumor Cell","conceptCode":"C63797","definition":"A metastatic cancer cell found in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0E811F0-F360-3136-E040-BB89AD430E1B","latestVersionIndicator":"Yes","beginDate":"2011-04-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-04-14","modifiedBy":"GDEEN","dateModified":"2023-08-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-92EC-1659-E053-F662850AAC42","beginDate":"2019-04-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Tissue Pharmacogenetics","valueDescription":"Tissue Pharmacogenetics","ValueMeaning":{"publicId":"3110928","version":"1","preferredName":"Tissue Pharmacogenetics","longName":"3110928","preferredDefinition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.: Pharmacogenetics is broadly defined as the effect of inheritance on individual variations in response to drugs and xenobiotics. These variations may involve individual differences in therapeutic efficacy or adverse drug reactions. (from Medscape)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pharmacogenetics","conceptCode":"C16973","definition":"The investigation of the impact of individual gene variations on drug responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"89404B82-0DA6-7C65-E040-BB89AD4377DC","latestVersionIndicator":"Yes","beginDate":"2010-06-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-91B6-1659-E053-F662850AAC42","beginDate":"2010-06-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Blood Pharmacogenetics","valueDescription":"Blood Pharmacogenetics","ValueMeaning":{"publicId":"3110929","version":"1","preferredName":"Blood Pharmacogenetics","longName":"3110929","preferredDefinition":"Blood circulating throughout the body.: Pharmacogenetics is broadly defined as the effect of inheritance on individual variations in response to drugs and xenobiotics. These variations may involve individual differences in therapeutic efficacy or adverse drug reactions. (from Medscape)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blood","conceptCode":"C12434","definition":"A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pharmacogenetics","conceptCode":"C16973","definition":"The investigation of the impact of individual gene variations on drug responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"89404B82-0DCC-7C65-E040-BB89AD4377DC","latestVersionIndicator":"Yes","beginDate":"2010-06-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-91C0-1659-E053-F662850AAC42","beginDate":"2010-06-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Blood Panitumumab antibody","valueDescription":"Blood Panitumumab antibody","ValueMeaning":{"publicId":"3110930","version":"1","preferredName":"Blood Panitumumab antibody","longName":"3110930","preferredDefinition":"Blood Panitumumab antibody","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"89404B82-0DEF-7C65-E040-BB89AD4377DC","latestVersionIndicator":"Yes","beginDate":"2010-06-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-91CA-1659-E053-F662850AAC42","beginDate":"2010-06-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Blood AMG 479 antibody","valueDescription":"Blood AMG 479 antibody","ValueMeaning":{"publicId":"3110931","version":"1","preferredName":"Blood AMG 479 antibody","longName":"3110931","preferredDefinition":"Blood AMG 479 antibody","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"89404B82-0E12-7C65-E040-BB89AD4377DC","latestVersionIndicator":"Yes","beginDate":"2010-06-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86BE9973-91D4-1659-E053-F662850AAC42","beginDate":"2010-06-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","deletedIndicator":"No"},{"value":"Metabolic profiling and cell free DNA","valueDescription":"Metabolomics And Circulating Cell-Free DNA","ValueMeaning":{"publicId":"6898022","version":"1","preferredName":"Metabolomics And Circulating Cell-Free DNA","longName":"6898022","preferredDefinition":"Metabolomics is the study of the biological metabolic profile of a cellular specimen in a specific environment at an isolated timepoint. This discipline depicts the physiological states of cells and organisms by focusing on carbohydrates, lipids, and other metabolites. Several analytical techniques are utilized to quantify the metabolic content of specimens such as mass spectrometry and electrophoretic applications.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: DNA that is found in blood plasma and is not associated with cells in the circulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metabolomics","conceptCode":"C49019","definition":"Metabolomics is the study of the biological metabolic profile of a cellular specimen in a specific environment at an isolated timepoint. This discipline depicts the physiological states of cells and organisms by focusing on carbohydrates, lipids, and other metabolites. Several analytical techniques are utilized to quantify the metabolic content of specimens such as mass spectrometry and electrophoretic applications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Circulating Cell-Free DNA","conceptCode":"C128274","definition":"DNA found in blood plasma and other bodily fluids that is not associated with cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"91BE2B50-B873-6879-E053-F662850A187E","latestVersionIndicator":"Yes","beginDate":"2019-09-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-04","modifiedBy":"ONEDATA","dateModified":"2019-09-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"91BE2B50-B88C-6879-E053-F662850A187E","beginDate":"2019-09-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-04","modifiedBy":"ONEDATA","dateModified":"2019-09-04","deletedIndicator":"No"},{"value":"Cell free DNA (cfDNA)","valueDescription":"Circulating cell-free DNA","ValueMeaning":{"publicId":"2578098","version":"1","preferredName":"Circulating cell-free DNA","longName":"2578098v1.00","preferredDefinition":"DNA found in blood plasma and other bodily fluids that is not associated with cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Circulating Cell-Free DNA","conceptCode":"C128274","definition":"DNA found in blood plasma and other bodily fluids that is not associated with cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FE1F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-02","modifiedBy":"GDEEN","dateModified":"2023-08-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95127034-2FC7-5A7F-E053-F662850AFD69","beginDate":"2019-10-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-16","modifiedBy":"ONEDATA","dateModified":"2019-10-16","deletedIndicator":"No"},{"value":"Metabolic profiling","valueDescription":"Metabolomics","ValueMeaning":{"publicId":"3945033","version":"1","preferredName":"Metabolomics","longName":"3945033","preferredDefinition":"Metabolomics is the study of the biological metabolic profile of a cellular specimen in a specific environment at an isolated timepoint. This discipline depicts the physiological states of cells and organisms by focusing on carbohydrates, lipids, and other metabolites. Several analytical techniques are utilized to quantify the metabolic content of specimens such as mass spectrometry and electrophoretic applications.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metabolomics","conceptCode":"C49019","definition":"Metabolomics is the study of the biological metabolic profile of a cellular specimen in a specific environment at an isolated timepoint. This discipline depicts the physiological states of cells and organisms by focusing on carbohydrates, lipids, and other metabolites. Several analytical techniques are utilized to quantify the metabolic content of specimens such as mass spectrometry and electrophoretic applications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA6365BC-F3FB-1753-E040-BB89AD431A40","latestVersionIndicator":"Yes","beginDate":"2013-11-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-11-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95127034-2FDB-5A7F-E053-F662850AFD69","beginDate":"2019-10-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-16","modifiedBy":"ONEDATA","dateModified":"2019-10-16","deletedIndicator":"No"},{"value":"Peripheral Blood Cytokine and Chemokine Profiles","valueDescription":"Blood Cytokine Expression Profile And Chemokine Expression Profile","ValueMeaning":{"publicId":"7008531","version":"1","preferredName":"Blood Cytokine Expression Profile And Chemokine Expression Profile","longName":"7008531","preferredDefinition":"A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.: The identification and quantitation of all of the cytokines expressed in a biological sample.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The identification and quantitation of all of the chemokines expressed in a biological sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blood","conceptCode":"C12434","definition":"A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Cytokine Expression Profile","conceptCode":"C129886","definition":"The identification and quantitation of all of the cytokines expressed in a biological sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chemokine Expression Profile","conceptCode":"C129894","definition":"The identification and quantitation of all of the chemokines expressed in a biological sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95312157-4233-3E1E-E053-F662850A4AED","latestVersionIndicator":"Yes","beginDate":"2019-10-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-18","modifiedBy":"ONEDATA","dateModified":"2019-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95312157-424C-3E1E-E053-F662850A4AED","beginDate":"2019-10-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-18","modifiedBy":"ONEDATA","dateModified":"2019-10-18","deletedIndicator":"No"},{"value":"Immune Cell Profiles","valueDescription":"Immune Cell Function Assay","ValueMeaning":{"publicId":"7008530","version":"1","preferredName":"Immune Cell Function Assay","longName":"7008530","preferredDefinition":"A set of laboratory assays that examine the responses of lymphoid or myeloid cells after exposure to an experimental material.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Cell Function Assay","conceptCode":"C73490","definition":"A set of laboratory assays that examine the responses of lymphoid or myeloid cells after exposure to an experimental material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95312157-420B-3E1E-E053-F662850A4AED","latestVersionIndicator":"Yes","beginDate":"2019-10-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-18","modifiedBy":"ONEDATA","dateModified":"2019-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95312157-4224-3E1E-E053-F662850A4AED","beginDate":"2019-10-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-18","modifiedBy":"ONEDATA","dateModified":"2019-10-18","deletedIndicator":"No"},{"value":"Circulating Tumor DNA (ctDNA)","valueDescription":"Circulating Tumor-Derived DNA","ValueMeaning":{"publicId":"4061103","version":"1","preferredName":"Circulating Tumor-Derived DNA","longName":"4061103v1.00","preferredDefinition":"Neoplasm-derived DNA found in blood plasma and other bodily fluids that is not associated with cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Circulating Tumor-Derived DNA","conceptCode":"C113243","definition":"Neoplasm-derived DNA found in blood plasma and other bodily fluids that is not associated with cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF8E6531-DBF4-0C48-E040-BB89AD432745","latestVersionIndicator":"Yes","beginDate":"2014-01-09","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-01-09","modifiedBy":"GDEEN","dateModified":"2023-08-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95312157-4260-3E1E-E053-F662850A4AED","beginDate":"2019-10-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-18","modifiedBy":"ONEDATA","dateModified":"2019-10-18","deletedIndicator":"No"},{"value":"Lymphocyte Subsets","valueDescription":"Subgroup Lymphocyte","ValueMeaning":{"publicId":"7295343","version":"1","preferredName":"Subgroup Lymphocyte","longName":"7295343","preferredDefinition":"A subdivision of a larger group with members often exhibiting similar characteristics.: White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each); those with characteristics of neither major class are called null cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subgroup","conceptCode":"C25693","definition":"A subdivision of a larger group with members often exhibiting similar characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymphocyte","conceptCode":"C12535","definition":"White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each); those with characteristics of neither major class are called null cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A5A16EF7-9151-0714-E053-F662850AC2F8","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A5A16EF7-916A-0714-E053-F662850AC2F8","beginDate":"2020-05-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3111293","version":"1","preferredName":"Specimen Gastrointestinal Urology Laboratory Procedure Type","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:(GAS-tro-in-TES-tih-nul) GI.  Refers to the stomach and intestines.:The medical specialty concerned with the study, diagnosis, and treatment of diseases of the genitourinary tract.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:Type; a subdivision of a particular kind of thing.","longName":"C19157:C13359:C17243:C25294:C2","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Gastrointestinal","conceptCode":"C13359","definition":"Pertaining to the stomach and intestines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Urology","conceptCode":"C17243","definition":"The medical specialty concerned with the study, diagnosis, and treatment of diseases of the genitourinary tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"894FFBD5-ACAD-5061-E040-BB89AD435F93","latestVersionIndicator":"Yes","beginDate":"2010-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-18","modifiedBy":"ONEDATA","dateModified":"2010-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86BE9973-91A1-1659-E053-F662850AAC42","latestVersionIndicator":"Yes","beginDate":"2010-06-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"KUMMEROA","dateModified":"2020-05-14","changeDescription":"Versioned to increase max length for additional PVs_ghd PV added for DCI. AK 2020-5-14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812724","version":"1","longName":"Duke U New CDEs","context":"NCIP"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]}],"AlternateNames":[{"name":"DCI","type":"USED_BY","context":"DCI"}],"ReferenceDocuments":[{"name":"Test","type":"Preferred Question Text","description":"Test","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86BE8949-9C1D-60B9-E053-F662850A0259","latestVersionIndicator":"Yes","beginDate":"2010-06-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-17","modifiedBy":"KUMMEROA","dateModified":"2020-05-26","changeDescription":"Curated to support Duke University trial in C3D; Versioned due to version of VD to increase max length_04.17.19_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}